Search Results - G. Huls

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Different Amounts of DNA in Newborn Cells of Escherichia coli Preclude a Role for the Chromosome in Size Control According to the “Adder” Model by Peter G. Huls, Norbert O. E. Vischer, Conrad L. Woldringh

    Published in Frontiers in Microbiology (2018-04-01)
    Get full text
    Article


  2. 2

    ISOFORMA ONCOGÊNICA δNP73 CONTRIBUI PARA AGRESSIVIDADE E RESISTÊNCIA AO ATRA NA LEUCEMIA PROMIELOCÍTICA AGUDA VIA REGULAÇÃO DO EIXO NANOG/BMP4 by CA Ortiz-Rojas, DA Pereira-Martins, CH Thomé, GA Ferreira, I Weinhauser, VMD Wagatsuma, L Pontes, G Huls, JJ Schuringa, EM Rego

    Published in Hematology, Transfusion and Cell Therapy (2024-10-01)
    Get full text
    Article


  3. 3

    P1415: HIGH AND LOW MYELOID SKEWING IN THE GENERAL POPULATION AND THE ASSOCIATION WITH CLONAL HEMATOPOIESIS by M. van Bergen, P. Kamphuis, I. van Zeventer, J. Salzbrunn, J. J. Schuringa, B. van der Reijden, A. de Graaf, G. Huls, J. Jansen

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    P440: THE COMBINATION VENETOCLAX PLUS MCL1 OVERCOMES DRUG RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA by D. A. Pereira-Martins, N. I. Noguera, T. Ottone, A. Diepstra, C. Ortiz, I. Weinhauser, G. Huls, J. J. Schuringa, E. M. Rego, E. Ammatuna

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    P439: ASSOCIATING EX VIVO DRUG SENSITIVITY WITH METABOLIC STATUS IDENTIFIES EFFECTIVE COMBINATION STRATEGIES IN ACUTE MYELOID LEUKEMIA by D. A. Pereira-Martins, E. Griessinger, I. Weinhauser, J. L. Coelho-Silva, D. R. Silveira, L. Quek, A. Erdem, J. R. Hilberink, E. V. de Paula, S. T. Olalla Saad, E. Ammatuna, G. Huls, E. M. Rego, A. R. Lucena-Araujo, J. J. Schuringa

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  6. 6

    P437: SURVIVAL-BASED 4-GENE PROGNOSTIC INDEX IMPROVES THE ELN-RISK CLASSIFICATION IN ACUTE MYELOID LEUKEMIA by C. A. Ortiz Rojas, D. A. Pereira-Martins, C. C. Bellido More, J. R. Hilberink, J. L. Coelho-Silva, I. Weinhäuser, L. Yamamoto de Almeida, V. M. de Deus Wagatsuma, C. Hassibe Thomé, G. Aguiar Ferreira, E. Ammatuna, G. Huls, J. J. Schuringa, E. Magalhães Rego

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  7. 7

    S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY (“3 + 7”) FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS: A RANDOMIZED PHASE III STUDY OF THE EORTC LEUKEMIA GROUP,... by M. Lübbert, P. Wijermans, M. Kicinski, S. Chantepie, W. van der Velden, R. Noppeney, L. Griskevicius, A. Neubauer, M. Crysandt, R. Vrhovac, M. Luppi, S. Fuhrmann, E. Audisio, A. Candoni, O. Legrand, R. Foà, G. Gaidano, D. van Lammeren-Venema, E. F. Posthuma, M. Hoogendoorn, A. Giraut, M. Stevens-Kroef, J. H. Jansen, E. Ammatuna, J.-P. Vilque, R. Wäsch, H. Becker, N. Blijlevens, U. Dührsen, F. Baron, S. Suciu, S. Amadori, A. Venditti, G. Huls

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: